Republica Cehă - cehă - SUKL (Státní ústav pro kontrolu léčiv)

zaklady farmaceutyczne polpharma sa, starogard gdański array - 41 monohydrÁt sitagliptin-hydrochloridu; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/1000mg - metformin a sitagliptin

Republica Cehă - cehă - SUKL (Státní ústav pro kontrolu léčiv)

zaklady farmaceutyczne polpharma sa, starogard gdański array - 41 monohydrÁt sitagliptin-hydrochloridu; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/850mg - metformin a sitagliptin

Republica Cehă - cehă - SUKL (Státní ústav pro kontrolu léčiv)

pharmaceutical works polpharma s.a., starogard gdaňski array - 1064 paracetamol; 2719 tramadol-hydrochlorid - potahovaná tableta - 37,5mg/325mg - tramadol a paracetamol

Republica Cehă - cehă - SUKL (Státní ústav pro kontrolu léčiv)

zaklady farmaceutyczne polpharma sa, starogard gdański array - 17381 apixaban - potahovaná tableta - 2,5mg - apixaban

Republica Cehă - cehă - SUKL (Státní ústav pro kontrolu léčiv)

zaklady farmaceutyczne polpharma sa, starogard gdański array - 17381 apixaban - potahovaná tableta - 5mg - apixaban

Republica Cehă - cehă - SUKL (Státní ústav pro kontrolu léčiv)

zaklady farmaceutyczne polpharma sa, starogard gdański array - 17768 tikagrelor - potahovaná tableta - 60mg - tikagrelor

Republica Cehă - cehă - SUKL (Státní ústav pro kontrolu léčiv)

zaklady farmaceutyczne polpharma sa, starogard gdański array - 17768 tikagrelor - potahovaná tableta - 90mg - tikagrelor

Uniunea Europeană - cehă - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologické látky - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Uniunea Europeană - cehă - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - pioglitazon, metformin hydrochloridu - diabetes mellitus, typ 2 - léky užívané při diabetu - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.

Uniunea Europeană - cehă - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - pioglitazon, glimepirid - diabetes mellitus, typ 2 - léky užívané při diabetu - tandemact je indikován k léčbě pacientů s diabetes mellitus typu 2, nesnášenlivostí k metforminu nebo pro koho metformin je kontraindikován a kteří jsou již léčeni kombinace pioglitazonu a glimepirid.